Promore Pharma AB (publ) filed its Annual on May 09, 2023 for the period ending Dec 31, 2022. In this report its auditor, Finnhammars, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.95 SEK | -2.45% | -5.92% | 0.00% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 15.7M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- PMDS Stock
- News PMD Device Solutions AB
- Promore Pharma AB Auditor Raises 'Going Concern' Doubt